Commentary on Provisional Cannabis Referendum Results
PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com
FOR PUBLIC RELEASE
NZX Limited
Wellington
5 November 2020
Rua Bioscience Commentary on Provisional Cannabis Referendum Results
The provisional result of the Cannabis Referendum announced on Friday 30 October has driven
significant discussion in the media and in the community. The discussion has highlighted that the
difference between medicinal cannabis and recreational cannabis is still not widely understood.
That lack of clarity has meant there has been an incorrect view that Rua Bioscience, which is a licenced
Medicinal Cannabis company, is impacted by the outcome (either a yes vote or a no vote) of the
Cannabis Referendum. This is not the case.
Ahead of the final result from the Cannabis Referendum being announced, the directors of Rua
Bioscience believe it is important to clearly restate that the company’s strategy set out in the Product
Disclosure Statement is to develop and primarily export pharmaceutical grade medicinal cannabis
products.
Rua Bioscience has no plans to enter the recreational cannabis market if cannabis is legalised in New
Zealand beyond the current provisions for medicinal cannabis.
Rua Bioscience is solely focussed on medicinal cannabis. Rua Bioscience is licenced under the
Medicinal Cannabis Access Scheme, which came into effect on 1 April 2020. In August, Rua was
granted one of the first commercial licences for cultivation, possession for manufacturing and supply
of pharmaceutical cannabis.
ENDS
For shareholder enquiries please visit www.ruabio.com, or contact:
Rob Mitchell
CEO, Rua Bioscience
media@ruabio.com
0800 RUABIO
About Rua Bioscience: Rua Bioscience is a New Zealand pharmaceutical company aiming to be a
leading producer of cannabinoid derived medicines for both export and local markets. Rua has been
an early mover in the sector and was the first private company in New Zealand to receive a licence to
cultivate cannabis for research purposes. Founded in 2017 in Ruatorea as a subsidiary of charitable
company Hikurangi Enterprises Limited, Rua is underpinned by its mission to heal the people and
heal the land. It is committed to New Zealand’s Te Tairāwhiti (East Coast) region and its connection
MARKET ANNOUNCEMENT
PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com
with its local community. The company has completed facilities for cultivation and manufacturing
and is currently going through the GMP certification process. www.ruabio.com
Rua Bioscience is trading under the name of Rua Bioscience Limited.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- RAD — Radius Residential Care Limited: Listing Profile2020-12-09
“We see a listing on the NZX Main Board as the first step in our next stage of growth, providing us with enhanced ability to quickly access capital to fund growth initiatives, as and when specific opportunities arise. We have a clear growth strategy to: • purchase strategical…”
- NZL — New Zealand Rural Land Company Limited: NZRLC Product Disclosure Statement2020-12-20
“8 New Zealand Rural Land Company Limited - Product Disclosure Statement 16 November 2020 Dear Investors, The rural sector is an important contributor to the New Zealand economy and a key part of our national identity. Its importance to New Zealand export receipts has been magnif…”
- BLT — BLIS Technologies Limited: Strong HY21 performance despite challenging mkt conditions2020-11-18
“Blis Technologies Limited: 81 Glasgow Street, South Dunedin 9012, PO Box 2208, Dunedin 9012, New Zealand T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz China Daigou and Cross border eCommerce (CBEC) COVID related restrictions on international travel has resulted…”